Last checked at 
Integrated Diagnostics Holdings PLC - consumer healthcare firm with operations in Egypt, Jordan, Sudan and Nigeria - Pretax profit improves to EGP969.1 million, about USD61.8 million, in 2020 from EGP758.1 million in 2019. Revenue grows to EGP2.66 billion from EGP2.23 billion. Number of branches rises to 481 from 452. Patients slip 5% to 7.1 million but revenue per patient up 25% year on year to EGP373. Declares final dividend of USD0.049, up 4% year on year.
Chair Anthony St John says: "I am pleased to report that against a backdrop of a very challenging year with the global Covid-19 pandemic, IDH has proven very resilient and rose to the challenge with an impressive set of results. We were able to leverage our well-established business model and track record to facilitate new revenue generating opportunities.
"We remained committed to our social responsibilities in providing high-quality healthcare to the countries where IDH have extended our footprint. We were able to provide much-needed PCR and other testing facilities in both Egypt and Jordan, while expanding our house call services. We are well-positioned to maintain our consistent strong growth track record and trajectory."
Current stock price: USD1.10, up 1.4% on Wednesday
Year-to-date change: flat
By Paul McGowan; paulmcgowan@alliancenews.com;
Copyright 2021 Alliance News Limited. All Rights Reserved.